[Changes in laboratory tests after treatment with a new contraceptive agent].
D000469:Alkaline Phosphatase / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology*; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D008659:Metabolic Diseases / Q000139:chemically induced*; D009644:Norgestrel / Q000031:analogs & derivatives* / Q000494:pharmacology; D011247:Pregnancy; D013960:Thyroid Function Tests; D013997:Time Factors; D000637:Transaminases / Q000097:blood
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D009644:Norgestrel; D004997:Ethinyl Estradiol; D002784:Cholesterol; D000637:Transaminases; D000469:Alkaline Phosphatase
Alteraciones en las pruebas de laboratorio después de tratamiento con un nuevo anovulatorio.